Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E F Wagner

Interstitial Lung Disease Induced by Gefitinib and Toll-Like Receptor Ligands Is Mediated by Fra-1

Oncogene

English

Anti-Oncogenic Activity of Signalling-Defective Epidermal Growth Factor Receptor Mutants.

Molecular and Cellular Biology

Cell Biology

Molecular Biology

1992

English

Related publications

MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands

English

A Common Path to Innate Immunity to HIV-1 Induced by Toll-Like Receptor Ligands in Primary Human Macrophages

PLoS ONE

Multidisciplinary

2011

English

Elevation of Serum Thioredoxin in Patients With Gefitinib-Induced Interstitial Lung Disease

Internal Medicine

Medicine

2007

English

Accelerated Wound Healing Mediated by Activation of Toll-Like Receptor 9

Wound Repair and Regeneration

Dermatology

Surgery

2010

English

Differential Inhibition of Human Cytomegalovirus (HCMV) by Toll-Like Receptor Ligands Mediated by Interferon-Beta in Human Foreskin Fibroblasts and Cervical Tissue

English

Vein Graft Disease Is Prevented by Toll-Like Receptor 3 via Type-I Interferon Induced Decrease of Inflammatory Responses

European Journal of Vascular and Endovascular Surgery

Surgery

Cardiovascular Medicine

Cardiology

2018

English

Endogenous Toll-Like Receptor Ligands and Their Biological Significance

Journal of Cellular and Molecular Medicine

Molecular Medicine

Cell Biology

2010

English

Mechanisms of Dexamethasone-Mediated Inhibition of Toll-Like Receptor Signaling Induced by Neisseria Meningitidis and Streptococcus Pneumoniae

Infection and Immunity

English

Phosphatidylglycerol Inhibits Toll-Like Receptor-Mediated Inflammation by Danger-Associated Molecular Patterns

Journal of Investigative Dermatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E F Wagner

Interstitial Lung Disease Induced by Gefitinib and Toll-Like Receptor Ligands Is Mediated by Fra-1

Anti-Oncogenic Activity of Signalling-Defective Epidermal Growth Factor Receptor Mutants.

Related publications

MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands

A Common Path to Innate Immunity to HIV-1 Induced by Toll-Like Receptor Ligands in Primary Human Macrophages

Elevation of Serum Thioredoxin in Patients With Gefitinib-Induced Interstitial Lung Disease

Accelerated Wound Healing Mediated by Activation of Toll-Like Receptor 9

Differential Inhibition of Human Cytomegalovirus (HCMV) by Toll-Like Receptor Ligands Mediated by Interferon-Beta in Human Foreskin Fibroblasts and Cervical Tissue

Vein Graft Disease Is Prevented by Toll-Like Receptor 3 via Type-I Interferon Induced Decrease of Inflammatory Responses

Endogenous Toll-Like Receptor Ligands and Their Biological Significance

Mechanisms of Dexamethasone-Mediated Inhibition of Toll-Like Receptor Signaling Induced by Neisseria Meningitidis and Streptococcus Pneumoniae

Phosphatidylglycerol Inhibits Toll-Like Receptor-Mediated Inflammation by Danger-Associated Molecular Patterns